| Native bovine bone morphogenetic protein in the healing of segmental long bone defects | ||
|---|---|---|
| Prev | ||
Aldinger G, Herr G, Kusswetter W, Reis HJ, Thielemann FV & Holz U (1991) Bone morphogenetic protein: a review. Int Orthop 15:169–77.
Alpaslan C, Irie K, Takahashi K, Ohashi N, Sakai H, Nkajima T & Ozawa H (1996) Long-term evaluation of recombinant human bone morphogenetic protein-2 induced bone formation with a biologic and synthetic delivery system. Br J Oral Maxillofac Surg 34(5):414–8.
An YH & Friedman RJ (1999) Animal models in bone defect. In: An YH & Friedman RJ (1999) Animal models in orthopaedic research. CRC Press LLC, Boca Raton, USA. Animal models in bone defect repair, p. 241–260.
Arnaud E, De Pollak C, Meunier A, Sedel L, Damien C & Petite H (1999) Osteogenesis with coral is increased by BMP and BMC in a rat cranioplasty. Biomaterials 20(20):1909–18.
Asahina I, Watanabe M, Sakurai N, Mori M & Enomoto S (1997) Repair of bone defect in primate mandible usinf a bone morphogenetic protein (BMP)-hydroxyapatite-collagen composite. J Med Dent Sci 44:63–70.
Bai MH, Liu XY, Ge BF, Yallg C & Chen DA (1996) An implant of a composite of bovine bone morphogenetic protein and plaster of paris for treatment of femoral shaft nonunions. Int Surg 81(4):390–2.
Barboza E, Caula A & Machado F (1999) Potential of recombinant human bone morphogenetic protein-2 in bone regeneration. Implant Dent 8(4):360–7.
Bax BE, Wozney JM & Ashhurst DE (1999) Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia. Calcif Tissue Int 65(1):83–9.
Bessho K, Tagawa T & Murata M (1989) Purification of bone morphogenetic protein derived from bovine bone matrix. Biochem Biophys Res Commun 165(2):595–601.
Bessho K, Tagawa T & Murata M (1991a) Analysis of bone morphogenetic protein (BMP) derived from human and bovine bone matrix. Clin Orthop 268:226–33.
Bessho K, Tagawa T & Murata M (1991b) Analysis of bone morphogenetic protein (BMP) derived from human and bovine bone matrix. Clin Ortop 268:226–34.
Bessho K, Kusumoto K, Fujimura K, Konishi Y, Ogawa Y, Tani Y & Iizuka T (1999) Comparison of recombinant and purified human bone morphogenetic protein. Br J Oral Maxillofac Surg 37(1):2–5.
Block JE & Poser J (1995) Does Xenogeneic demineralized bone matrix have clinical utility as a bone graft substitute? Medical Hypotheses 45:27–32.
Boden SD, Martin GJ, Morone MA, Ugbo JL & Moskovitz PA (1999) Posterolateral lumbar intertransverse processus spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine 24(12):1179–85.
Boden SD, Zdeblich TA, Sandhu HS & Heim SE (2000) The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans:A preliminary report. Spine 25(3):376–81.
Bolander ME & Balian G (1986) The use of demineralized bone matrix in the repair of segmental defects. J Bone Joint Surg 68–A (8):1264–74.
Boström MPG, Lane JM, Berberian WS, Missri AAE, Tomin E, Weiland A, Doty SB, Glacer D & Rosen VM (1995) Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13(3):357–67.
Boström M, Lane JM, Tomin E, Browne M, Berberian W, Turek T, Smith J, Wozney J & Schildhauer T (1996) Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop 327:272–82.
Boström MPG & Camancho NP (1998) Potential role of bone morphogenetic protein in fracture healing. Clin Orthop 355S:S274–S282.
Boström MP, Saleh KJ & Einhorn TA (1999) Osteoinductive growth factors in preclinical fracture and long bone defects models. Orthop Clin North Am 30(4):647–58.
Boyne PJ (1996) Animal studies of application of rhBMP-2 in maxillofacial reconstruction. Bone 19(1 Suppl):83S–92S.
Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M & Nummikoski P (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Dent 17(1):11–25.
Bruder SP, Kraus KH, goldberg VM & Kadiyala S (1998) The effect of implants loaded with autologous mesenchymal stern cells on healing of canine segmental bone defects. J Bone Joint Surg 80A: 985–996.
Bruder SP & Fox BS (1999) Tissue engineering of bone. Cell based strategies. Clin Orthop 367S:S68–S83.
Bucholz RW, Carlton A & Holmes RE (1987) Hydroxyapatite and tricalcium phosphate bone graft substittutes. Orthop Clin North Am 18:323–34.
Bucholz RW, Carlton A & Holmes R (1989) Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin Orthop 240:53–62.
Burchardt H, Jones H, Glowczewskie F, Rudner C & Enneking WF (1978) Freeze-dried allogeneic segmental cortical-bone grafts in dogs. J Bone Joint Surg 60–A(8):1082–90.
Burt DW & Law AS (1994) Evolution of the transforming growth factor-beta superfamily. Prog Growth Factor Res 5(1):99–118.
Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA & Wozney JM (1990) Identification of transforming growth factor beta family members present in bone-inductive protein purified in bovine bone. Proc Natl Acad Sci USA 87(24):9843–47.
Chen P, Carrington JL, Hammonds RGJ & Reddi AH (1991) Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2B (BMP-2B) and modulation by transforming growth factor beta 1 and beta 2. Exp Cell Res 195:509–15.
Chiroff RT, White EW, Weber JN & Roy DM (1975) Tissue ingrowth of replamineform implants. J. Biomed Mater Res 6: 29–45.
Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC & Whitecloud TS (1994a) The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg 76–A (6):827–38.
Cook SD, Baffes GC, Wolfe MW, Sampath TK & Rueger DC (1994b) Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop 301:302–312.
Cook SD, Wolfe MW, Salkeld SL & Rueger DC (1995) Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg 77–A (5):734–50.
Cook SD, Salkeld SL, Brinker MR, Wolfe MW & Rueger DC (1998) Use of an osteoinductive biomaterial (rhOP-1) in healing large segmental bone defects. J Orthop Trauma 12(6):407–12.
Cook SD (1999) Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. Orthopaedics 22(7):669–71.
Damien CJ, Parsons JR, Benedict JJ & Weisman DS (1990) Investigation of a hydroxyapatite and calcium sulfate composite supplemented with an osteoinductive factor. J Biomed Mater Res 24:639–54.
David SM, Gruber HE, Meyer RA Jr, Murakami T, Tabor OB, Howard BA, Wozney JM & Hanley EN Jr (1999) Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers. Spine 24(19):1973–9.
de Groot J (1998) Carriers that concentrate native bone morphogenetic protein in vivo. Tissue Eng 4(4):337–41.
Delloye C, Coutelier L, Vincent A, d`Hemricourt J & Bourgois R (1986) Canine cortical bone autograft remodeling in two simultaneous skeletal sites. Arch Orthop Trauma Surg 105:79–99.
Delloye C, Verhelpen M, d`Hemricourt J, Govaerts B & Bourgois R (1992) Morphometric and physical investigations of segmental cortical bone autografts and allografts in canine ulnar defects. Clin Orthop 282:273–92.
Dewulf N, Verschueren K, Lonnoy O, Moren A, Grimsby S, Vande Spiegel K, Miyazono K, Huylebroeck D & ten Dijke P (1995) Distinct spinal and temporal expression patterns of two type I receptor for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136:2652–2663.
Dube J & Celeste AJ (1996a) Human bone morphogenetic protein-13, a molecule which is highly related to human morphogenetic protein-12. J Bone Miner Res 11:S336.
Dube J & Celeste AJ (1996b) Human bone morphogenetic protein-15, a new member of the transforming growth factor-ß superfamily.J Bone Miner Res 11:S336.
Einhorn TA, Lane JM, Burstein AH, Kopman CR & Vigorita VJ (1984) The healing of segmental bone defects by demineralized bone matrix. J Bone Joint Surg 66–A (2):274–9.
Einhorn TA (1999) Clinically applied models of bone regeneration in tissue engineering research. Clin Orthop 367S:S59–S67.
Elsinger E & Leal L (1995) Coralline hydroxyapatite bone graft substitutes. J Foot Ankle Surg 35:396–9.
Enneking WF, Burchardt H, Puhl JJ & Pietrowski G (1975) Physical and biological aspects in dog cortical-bone transplants. J Bone Joint Surg 57–A (2):237–52.
Fang J, Zhu YY, Smiley E, Bonadio J, Rouleau JP, Goldstein SA, McCauley LK, Davidson BL & Roessler BJ (1996) Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Nat Acad Sci 93:5753–58.
Flechtenmacher J, Huch K, Thonar EJ, Mollenhauer JA, Davies SR, Schmid TM, Puhl W, Sampath TK, Aydelotte MB & Kuettner KE (1996) Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum 39(11):1896–904.
Forslund C & Aspenberg P (1998) OP-1 has more effect than mechanical signals in the control of tissue differentation in healing rat tendons. Acta Orthop Scand 69(6):622–6.
Friedlaender GE (1983) Immune responses to osteochondral allografts. Current knowledge and future directions. Clin Orthop 174:58–68.
Gao TJ & Lindholm TS (1993a) Functional carriers for bone morphogenetic proteins. Ann Chir Gynaecol 82:3–12.
Gao TJ, Lindholm TS, Marttinen A & Puolakka T (1993b) Bone inductive potential and dose-dependent response of bovine bone morphogenetic protein combined with type IV collagen carrier. Ann Chir Gynaecol 82:77–84.
Gao TJ, Lindholm TS, Kommonen B, Ragni P, Paronzini A & Lindholm TC (1995) Microscopic evaluation of bone-implant contact between hydroxyapatite, bioactive glass and tricalcium phosphate implanted in sheep diaphyseal defects. Biomaterials 16:1175–9.
Gao TJ, Lindholm TS, Marttinen A & Urist MR (1996a) Composites of bone morphogenetic protein (BMP) and type IV collagen, coral-derived coral hydroxyapatite, and tricalcium phosphate ceramics. Int Orthop 20:321–5.
Gao TJ, Lindholm TS, Kommonen B, Ragni A, Paronzini A, Lindholm TC, Jämsä T & Jalovaara P (1996b) Enhanced healing of segmental tibial defects in sheep by a composite bone substitute composed of tricalcium phosphate cylinder, bone morphogenetic protein, and type IV collagen. J Biomed Mater Res 32:505–12
Gao TJ, Lindholm TC, Marttinen A, Viljanen V & Lindholm TS (1996c) Bone induction and immune occurrence in bone morphogenetic protein. In: Lindholm TS (ed.): Bone morphogenetic proteins:Biology, biochemistry and reconstructive surgery. R.G.Landes Company, Austin, USA.
Gao TJ, Lindholm TS, Kommonen B, Ragni P, Paronzini A, Lindholm TC, Jalovaara P & Urist MR (1997) The use of coral composite implant containing bone morphogenetic protein to repair a segmental tibial defect in sheep. Int Orthop 21:194–200.
Garbuz DS, Masri BA & Czitrom AA (1998) Biology of allografting. Orthop Clin North Am 29(2):199–204.
Geesink RG, Hoefnagels NH & Bulstra SK (1999) Osteogenic activity of OP-1 bonemorphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 81(4):710–8.
Gerhart TN, Kirker-Head CA, Kritz MJ, Holtrop ME, Hennig GE, Hipp J, Schelling SH & Wang EA (1993) Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein (BMP-2). Clin Orthop 293:317–26.
Goldberg VM & Stevenson S (1987) Natural history of autografts and allografts. Clin Orthop 225:7–16.
Grgic M, Jelic M, Basic V, Basic N, Pecina M & Vukicevic S (1997) Regeneration of articular cartilage defects in rabbits by osteogenic protein-1 (bone morphogenetic protein-7). Acta Med Croatica 51(1):23–7.
Groeneweld EHJ, Van Den Bergh JPA, Ten Bruggenkate CM, Tuinzing DB & Burger EH (1999) Histomorphometrical analysis of bone formed in human maxillary sinus floor elevations grafted with OP-1 device, demineralized bone matrix or autogenous bone. Comparison with non-grafted sites in a series of case reports. Clin Oral Impl Res 10(6):499–509.
Groeneveld EHJ & Burger EH (2000) Bone morphogenetic proteins in human bone regeneration. European Journal of Endocrinology 142:9–21.
Gross TP, Jinnah RH, Clarke HJ & Cox QGN (1991) The biology of bone grafting. Orthopaedics 14(5):563–8.
Grundel RE, Chapman MW, Yee T & Moore DC (1991) Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clin Orthop 266:244–58.
Guillemin G, Patat J-L, Fournie J & Chetail M (1987) The use of coral as a bone graft substitute. J Biomed Mat Res 21:557–67.
Guizzardi S, Di Silvestre M, Scandroglio R, Ruggeri A & Savini R (1992) Implants of heterologous demineralized bone matrix for induction of posterior spinal fusion in rats. Spine 17(6):701–7.
Hashizume H, Tamaki T, Oura H & Minamide M (1998) Changes in the extracellular matrix on the surface of sintered bovine bone implanted in the femur of a rabbit:An immunohistochemical study. J Orthop Sci 3:42–53.
Hecht BP, Fischgrund JS, Herkowitz HN, Penman L, Toth JM & Shirkhoda A (1999) The use of recombinant human bone morphogenetic protein 2(rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine 24(7):629–36.
Heckman JD, Boyan BD, Aufdemorte TB & Abbott JT (1991) The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg 73–A;5:750–64.
Heckman JD, Ehler W, Brooks BP, Aufdemorte TB, Lohmann CH, Morgan T & Boyan BD (1999) Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal non-unions implanted with a biodegradable composite polymer. J Bone Joint Surg 81–A(12):1717–29.
Heiple KG, Chase SW & Herndon CH (1963) A comparative study of the healing process following different types of bone transplantation. J Bone Joint Surg 45–A:1593–1616.
Heise U, Osborn JF & Duwe F (1990) Hydroxyapatite ceramic as a bone substitute. Int Orthop 14: 329–338.
Higuchi T, Kinoshita A, Takahashi K, Oda S & Ishikawa I (1999) Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. J Periodontol 70(9):1026–31.
Hogan BLM (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580–94.
Hollinger JO, Schmitz JP, Mark DE & Seyfer AE (1990) Osseus wound healing with xenogeneic bone implants with a biodegradable carrier. Surgery 107(1):50–54.
Hollinger JO & Seyfer AE (1994) Bioactive factors and biosynthetic materials in bone grafting. Clinics in Plastic Surgery 21(3):415–18.
Hollinger JO & Leong K (1996) Poly(alpha-hydroxy acids):carriers for bone morphogenetic proteins. Biomaterials 17(2)187–94.
Holmes RE, Bucholz RW & Mooney W (1986) Porous hydroxyapatite as a bone graft substitute in metaphyseal defects. J Bone Joint Surg 68–A:904–11.
Hopp SG, Dahners LE & Gilbert JA (1989) A study of the mechanical strength of long bone defects treated with various bone autograft substitutes: an experimental investigation in the rabbit. J Orthop Res 7(4):579–84.
Horisaka Y, Okamoto Y, Matsumoto N, Yoshimura Y, Kawada J, Yamashita K & Takagi T (1991) Subperiosteal implantation of bone morphogenetic protein adsorbed to hydroxyapatite. Clin Orthop 268:303–12.
Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Lilly L & Cochran D (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodont Rest Dent 12:97–1110.
Huggins C (1931) The formation of bone under the influence of epithelium of the urinary tract. Arch Surg 22:377–408.
Isobe M, Yamazaki Y, Mori M & Amagasa T (1999) Bone regeneration produced in rat femur by polymer capsules containing recombinant human bone morphogenetic protein-2. J Oral Maxillofac Surg 57:695–8.
Itoh T, Mochizuki M, Nishimura R, Matsunaga S, Kadosawa T, Kokubo S, Yokota S & Sasaki N (1998) Repair of ulnar segmental defect by recombinant human bone morphogenetic protein-2 in dogs. J Vet Med Sci 60(4):451–8.
Jämsä T & Jalovaara P (1996) A cost-effective, accurate machine for testing torsional strength of sheep long bones. Med Eng Phys 18:433–435.
Johnson AL & Stein LE (1988) Morphologic comparison of healing patterns in ethylene oxide-sterilized cortical allografts and untreated cortical autografts in the dog. Am J Vet Res 49(1):101–5.
Johnson EE, Urist MR & Finerman GAM (1988a) Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. Clin Orthop 230:257–65.
Johnson EE, Urist MR & Finerman GAM (1988b) Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. Clin Orthop 236:249–57.
Johnson EE, Urist MR, Schmalzried TP, Chotivichit A, Huang HK & Finerman GAM (1989) Autogeneic cancellous bone grafts in extensive segmental ulnar defects in dogs. Clin Orthop 243:254–65.
Johnson EE, Urist MR & Finerman GAM(1990) Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation and human bone morphogenetic protein (hBMP). Clin Orthop 250:234–240.
Johnson EE, Urist MR & Finerman GAM (1992) Resistant nonunions and partial or complete segmental defects of long bones. Clin Orthop 277:229–37.
Johnson EE & Urist MR (2000) Human bone morphogenetic protein allografting for reconstruction of femoral nonunion. Clin Orthop 371:61–74.
Johnson KD, August A, Sciadini MF & Smith C (1996a) Evaluation of ground cortical autograft as a bone graft material in a new canine bilateral segmental long bone defect model. J Orthop Trauma 10(1):28–36.
Johnson KD, Frierson KE, Keller TS, Cook C, Scheinberg R, Zerwekh J, Meyers L & Sciadini MF (1996b) Porous ceramics as bone graft substitutes in long bone defects:A biomechanical, histological and radiographic analysis. J Orthop Res 14:351–69.
Jortikka L, Marttinen A & Lindholm TS (1993a) Purification of monocomponent bovine bone morphogenetic protein in a water-soluble form. Ann Chir Gynaecol 82:25–30.
Jortikka L, Marttinen A & Lindholm TS (1993b) Partially purified reindeer (Rangifer tarandus) bone morphogenetic protein has a high bone-forming activity compared with some other artiodactyls. Clin Orthop 297:33–37.
Kamegai A, Shimamura N, Naitou K, Nagahara K, Kanematsu N & Mori M (1994) Bone formation under the influence of bone morphogenetic protein/self-setting apatite cement composite as a delivery system. Biomed Mater Eng 4(4):291–307.
Kenley R, Marden LJ, Turek T, Jin L, Ron E & Hollinger JO (1994) Osseus regeneration in the rat calvarium using novel delivery systems for recombinant human bone moprhognetic protein 2 (rhBMP-2). J Biomed Mater Res 28:1139–47.
Kessler E, Takahara K, Biniaminov L, Brusel M & Greenspan DS (1996) Bone morphogenetic protein-1:The type I procollagen C-proteinase. Science 271(5247):360–2.
Key JA (1934) The effect of a local calcium depot on osteogenesis and healing of fractures. J Bone Joint Surg 16–A:176–84.
Kienapfel H, Sumner DR, Turner TM, Urban RM & Galante JO (1992) Efficacy of autograft and freeze-dried allograft to enhance fixation of porous coated implants in the presence of interface gaps. J Orthop Res 10(3):423–33.
Kirker-Head CA, Gerhart TN, Armstrong R, Schelling SH & Carmel LA (1998) Healing bone using recombinant human bone morphogenetic protein 2 and copolymer. Clin Orthop 349:205–217.
Klein-Nulend J, Louwerse RT, Heyligers IC, Wuisman PI, Semeins CM, Goei SW & Burger EH (1998) Osteogenic protein (OP-1, BMP-7) stimulates cartilage differentation of human and goat perichondrium tissue in vitro. J Biomed Mater Res 40(4):614–20.
Koempel JA, Patt BS, O"Grady K, Wozney J & Toriumi DM (1998) The effect of recombinant human bone morphogenetic protein-2 on the integration of porous hydroxyapatite implants with bone. J Biomed Mater Res 41:359–63.
Kotani S, Fujita Y, Kitsugi T, Nakamura T, Yamamuro T, Ohtsuki C & Kokubo T (1991) Bone bonding mechanism of beta-tricalcium phosphate. J Biomed Mater Res 25:1303–15.
Kuboki Y, Takita H, Kobayashi D, Tsuruga E, Inoue M, Murata M, Nagai N, Dohi Y & Ohgushi H (1998) BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures:topology of osteogenesis. J Biomed Mater Res 39(2):190–9.
Laitinen M (1999) Osteoinductivity mediated by malignant bone tumor-derived bone morphogenetic proteins: in vivo and in vitro models. Thesis, Acta Universitatis Tamperensis, 665.
Lane JM, Yasko AW, Tomin E, Cole BJ, Waller S, Browne M, Turek T & Gross J (1999a) Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. Clin Orthop 361:216–227.
Li SW, Sieron AL, Fertala A, Hojima Y, Arnold WV & Prockop DJ (1996) The C-proteinase that processes procollagens to fibrillar collagens is identical to the protein previously identified as bone morphogenetic protein-1. Proc Natl Acad Sci USA 93(10):5127–30.
Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee YP, Kabo JM, Finerman GAM, Berk AJ & Witte ON (1999) The effect of regional gene therapy with bone morphogenetic protein-2 producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg 81-A(7):905–17.
Lietman SA, Yanagishita M, Sampath TK & Reddi AH (1997) Stimulation of proteoglycan synthesis in explants of porcine articular cartilage by recombinant osteogenic protein-1 (bone morphogenetic protein-7). J Bone Joint Surg 79–A:1132–7.
Lindholm TC, Lindholm TS, Alitalo I & Urist MR (1988) Bovine morphogenetic protein (bBMP) induced repair of skull trephine defects in sheep. Clin Orthop 227:265–8.
Lindholm TC, Lindholm TS, Marttinen A & Urist MR (1994) Bovine bone morphogenetic protein (bBMP/NCP)-induced repair of skull trephine defects in pigs. Clin Orthop 301:263–70.
Lindholm TS, Ragni P & Lindholm TC (1988) Response of bone marrow stroma cells to demineralized bone matrix in experimental spine fusion in rabbits. Clin Orthop 230:296–302.
Lindholm TS, Marttinen A, Mattila M & Ala-Mononen P (1992) Biological activity of BMP bound to type I and IV collagen :a preliminary report. In New trends in Bone Grafting, Lindholm TS, ed., University of Tampere, Finland, 45.
Lindholm TS & Gao TJ (1993) Functional carriers for bone morphogenetic proteins. Ann Chir Gynaecol 82:3–12.
Magan A & Ripamonti U (1996) Geometry of porous hydroxyapatite implants influences osteogenesis in baboons. J Craniofac Surg 1(7):71–8.
Malinin TI (1992) Transplantation and banking of bone allografts. In New trends in bone grafting, University of Tampere, Tampere, Finland.
Marcacci M, Kon E, Zaffagnini S, Giardino R, Rocca M, Corsi A, Benvenuti A, Bianco P, Quarto R, Martin I, Muraglia A & Cancedda R (1999) Reconstruction of extensive long-bone defects in sheep using porous hydroxyapatite sponges. Calcif Tissue Int 64:83–90.
Martin GJ Jr, Boden SD, Marone MA & Moskovitz PA (1999) Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier and safety. J Spinal Disord 12(3):179–86.
Marttinen A, Lindholm TS, Jortikka L, Julkunen M & Sihvo H (1992) Purification of monocomponent bone morphogenetic protein in a water-soluble form. In: New trends in bone grafting. University of Tampere, Ser B, vol 40, 1992, Tampere, Finland.
Massagae J, Attisano L & Wrana JL (1994) The TGF-ß family and its composite receptors. Trends Cell Biol 4:172–8.
Mehlisch DR, Taylor TD, Leibold DG, Hiatt R, Waite DE, Waite PD, Laskin DM & Smith ST (1988) Collagen/hydroxylapatite implant for augmenting deficient alveolar ridges. J Oral Maxillofac Surg 44:839.
Meyer RA, Gruber HE, Howard BA, Tabor OB, Murakami T, Kwiatkowski TC, Wozney JM & Hanley EN (1999) Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog. Spine 24(8):747–54.
Minamide A, Tamaki T, Kawakami M, Hashizume H, Yoshida M & Sakata R (1999) Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2. Spine 24(18):1863–72.
Miyazono K (1999) Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 25(1):91–3.
Moore DC, Chapman MW & Manske D (1987) The evaluation of a biphasic calcium phosphate ceramic for use in grafting long-bone diaphyseal defects. J Orthop Res 5(3):356–65.
Morone MA, Boden SD, Hair G, Martin GJ, Racine M, Titus L & Hutton WC (1998) Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2. Clin Orthop 351:252–65.
Murata M, Huang BZ, Shibata T, Imai S, Nagai N & Arisue M (1999) Bone augmentation by recombinant human BMP-2 and collagen on adult rat parietal bone. Int J Oral Maxillofac Surg 28(3):232–7.
Muschler GF, Hyodo A, Manning T, Kambic H & Easley K (1994) Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin Orthop 308:229–40.
Nakase T, Nomura S, Yoshikawa H, Hashimoto J, Hirota S, Kitamura Y, Oikawa S, Ono K & Takaoka K (1994) Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 9(5):651–9.
Neo M, Kotani S, Fujita Y, Nakamura T, Yamamuro T, Bando Y, Ohtsuki C & Kokubo T (1992) Differences in ceramic-bone interface between surface-active ceramics and resorbable ceramics: a study by scanning and transmission electron microscopy. J Biomed Mater Res 26:255–67.
Niederwanger M & Urist MR (1996) Demineralized bone matrix supplied by bone banks for a carrier of recombinant human bone morphogenetic protein (rhBMP-2): a substitute for autogeneic bone grafts. J Oral Implantol 22(3–4):210–5.
Nilsson OS, Urist MR, Dawson EG, Schmalzried TP & Finerman GAM (1986) Bone repair induced by morphogenetic protein in ulnar defects in dogs. J Bone Joint Surg 68–B(4):635–42.
NiyibitziC, Baltzer A, Lattermann C, Oyama M, Whalen JD, Robbins PD & Evans CH (1998) Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop 355S:S148–53.
Noshi T, Yoshikawa T, Ikeuchi M, Dohi Y, Ohgushi H, Horiuchi K, Sugimura M, Ichijama K & Yonemasu K (2000) Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein. J Biomed Mater Res 52(4):621–30.
Nottbaert M, Lane JM, Burstein JA, Schneider R, Klein Ch, Sinn RS, Dowling Ch, Cornell Ch & Catsimpoolas N (1989) Omental angiogenic lipid fraction and bone repair, An experimental Study in the rat. J Orthop Res /:157–69.
Ohura K, Hamanishi C, Tanaka S & Matsuda N (1999) Healing of segmental bone defects in rats induced by a beta-TCP-MCPM cement combined with rhBMP-2. J Biomed Mater Res 44(2):168–75.
Oikarinen J & Korhonen LK (1979) The bone inductive capacity of various bone transplanting materials used for treatment of experimental bone defects. Clin Orthop 140:208–15.
Oikarinen J (1982) Experimental spinal fusion with decalcified bone matrix and deep-frozen allogeneic bone in rabbits. Clin Orthop 162:210–8.
Ono I, Gunji H, Kaneko F, Saito T & Kuboki Y (1995) Efficacy of hydroxyapatite ceramic as a carrier for recombinant human bone morphogenetic protein. J Craniofac Surg 6(3):238–44.
Ono I, Inoue M & Kuboki Y (1996) Promotion of the osteogenic activity of recombinant human bone morphogenetic protein by prostaglandin E1. Bone 19(6):581–8.
Paramore CG, Lauyryssen C, Rauzzino MJ, Wadlington VR, Palmer CA, Brix A, Cartner SC & Hadley MN (1999) The safety of OP-1 for lumbar fusion with decompression – a canine study. Neurosurgery 44(5):1151–5.
Pelker RR, Friedlaender GE, Markham TE, Panjabi MM & Moen CJ (1984) Effects of freezing and freeze-drying on the biomechanical properties of rat bone. J Orthop Res 1:405–11.
Peltola M (2001) Bioactive glass in frontal sinus and calvarial bone defect obliteration. Experimental and Clinical Studies. Thesis, Annales Universitatis Turkuensis, D 435.
Reddi AH, Wientroub S & Muthukumaran N (1987) Biologic principles of bone induction. Orthop Clin N Am 18(2):207–212.
Reddi AH (1998a) Initiation of fracture repair by bone morphogenetic proteins. Clin Orthop 355S:S66–72.
Reddi AH (1998b) Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16(3):247–52.
Reddi AH (2000) Morphogenesis and tissue engineering of bone and cartilage:inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng 6(4):351–9.
Riley EH, Lane JM, Urist MR, Lyons K & Liebermann JR (1996) Bone morphogenetic protein-2. Clin Orthop 324:39–46.
Ripamonti U, Ma SS, van de Heever B & Reddi AH (1992) Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induced rapid bone differentation in calvarial defects of adult primates. Plast Reconstr Surg 90:382–93.
Ripamonti U (1993) Delivery systems for bone morphogenetic proteins. A summary of experimental studies in primate models. Ann Chir Gynaecol 82:13–25.
Ripamonti U, Van Den Heever B, Sampath TK, Tucker MM, Rueger DC & Reddi AH (1996) Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (rhOP-1, bone morphogenetic protein-7). Growth Factors 13(3–4):273–89.
Roux FX, Bransnu D, Loty B, George B & Guillemin G (1988) Madreporic coral: A new bone graft substitute for cranial surgery. J Neurosurg 69:510–3.
Russell JL & Block JE (1999) Clinical utility of demineralized bone matrix for osseous defects, arthrodesis, and reconstruction:impact of processing techniques and atudy methodology. Orthopedics 22(5):524–31.
Sailor LZ, Hewick RM & Morris EA (1996) Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture. J Orthop Res 14:937–45.
Saitoh H, Takata T, Nikai H, Shintani H, Hyon SH & Ikada Y (1994) Effect of polylactic acid on osteoinduction of demineralized bone:preliminary study of the usefullness of polylactic acid as a carrier of bone morphogenetic protein. J Oral Rehabil 21(4):431–8.
Salama R & Weissman SL (1978) The clinical use of combined xenografts of bone and autologous red marrow. J Bone Joint Surg 60–B(1):111–15.
Sampath TK & Reddi AH (1981) Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentation. Proc Natl Acad Sci USA 78:7599–7603.
Sandhu HS, Kanim LEA & Kabo JM (1995) Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 20:2669–82.
Sato K & Urist MR (1985) Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. Clin Orthop 197:301–311.
Scaduto AA & Liebermann JR (1999) Gene therapy for osteoinduction. Orthop Clin North Am 30(4):625–33.
Schimandle JH, Boden SD & Hutton WC (1995) Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 20:1326–37.
Schmitt JM, Hwang K, Winn SR & Hollinger JO (1999) Bone morphogenetic proteins:An update on basic biology and clinical relevance. J Orthop Res 17(2):269–78.
Schwarz N, Schlag G, Thurnher M, Eschberger J, Dinges HP & Redl H (1991) :Fresh autogeneic, frozen allogeneic, and decalcified allogeneic bone grafts in dogs. J Bone Joint Surg 73–B:787–90.
Sciadini MF, Dawson JM & Johnson KD (1997a) Bovine-derived bone protein as a bone graft substitute in a canine segmental defect model. J Orthop Trauma 11(7):496–508.
Sciadini MF, Dawson JM & Johnson KD (1997b) Evaluation of bovine-derived bone protein with a natural coral carrier as a bone-graft substitute in a canine segmental defect model. J Orthop Res 15:844–57.
Sciadini MF & Johnson KD (2000) Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model. J Orthop Res 18(2):289–302.
Sellers RS, Zhang R, Glasson SS, Kim HD, Peluso D, D’Augusta DA, Beckwith K & Morris EA (2000) Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Bone Joint Surg 82–A(2):151–60.
Shapiro F, Koide S & Glimcher MJ (1993) Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg 75–A:532–53.
Sheehan JP, Kallmes DF, Sheehan JM, Jane JA Jr, Fergus AH, diPierro CG, Simmons NE, Makel DD & Helm GA (1996) Molecular methods of enhancing lumbar spine fusion. Neurosurgery 39(3):548–54.
Shibahara T, Noma H, Yama M, Ozawa Y & Yajima Y (1995) Purification and charecterization of bone morphogenetic protein derived from bovine bone matrix. Bull Tokyo Dent Coll 36(2):75–82.
Sigurdsson TJ, Nygaard L, Tatakis DN, Fu E, Turek TJ, Jin L, Wozney JM & Wikesjo UM (1996) Periodontal repair in dogs:evaluation of rhBMP-2 carriers. Int J Periodontics Retorative Dent 16(6):524–37.
Simmons DJ (1980) Fracture healing. In Urist MR: Fundamental and clinical bone physiology, Philadelphia, Pennsylvania, J.B.Lippincott, pp 283–330.
Stevenson S (1987) The immune response to osteochondral allografts in dogs. J Bone Joint Surg 69–A(4):573–82.
Stevenson S, Cunningham N, Toth J, Davy D & Reddi AH (1994) The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rat. J Bone Joint Surg 76–A(11):1676–87.
Takagi K & Urist MR (1982a) The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. Clin Orthop 171:224–31.
Takagi K & Urist MR (1982b) The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 196:100–109.
Takaoka K, Nakahara H, Yoshikawa H, Masuhara K, Tsuda T & Ono K (1988) Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin Orthop 234:250–4.
Takaoka K, Koezuka M & Nakahara H (1991) Telopeptide-depleted bovine skin collagen as a carrier for bone morphogenetic protein. J Orthop Res 9(6):902–7.
Teixeira JO & Urist MR (1998) Bone morphogenetic protein induced repair of compartmentalized segmental diaphyseal defects. Arch Orthop Trauma Surg 117(2):27–34.
Tielinen L (2000) The effect of bioabsorbable polylactide pins with polymer paste, containing transforming growth factor-β 1, on the healing of osteotomies and bone defects. Thesis, University of Helsinki.
Tomford WW & Mankin HJ (1999) Bone banking. Update on methods and materials. Orthop Clin North Am 30(4):565–70.
ToriumiDM, Kotler HS, Luxenberg DP, Holtrop ME & Wang EA (1993) Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 117:1101.
Toriumi DM, O"Grady K, Horlbeck DM, Desai D, Turek TJ & Wozney J (1999) Mandibular reconstruction using bone morphogenetic protein 2: long-term follw-up in a canine model. Laryngoscope 109(9):1481–9.
Urist MR & Iwata H (1979) A solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 76:1828–32.
Urist MR, Lietze A, Mizutani H, Takagi K, Triffitt JT, Amstutz J, DeLange R, Termine J & Finerman GA (1982) A bovine low molecular weight bone morphognetic protein (BMP) fraction. Clin Orthop 162:219–32.
Urist MR, Sato K, Brownell AG, Malinin TI, Lietze A, Huo YK, Prolo DJ, Oklund S, Finerman GAM & DeLange RJ (1983) Human bone morphogenetic protein (hBMP). Proc Soc Exp Biol Med 173:194–99.
Urist MR, Huo YK, Brownell AG, Hohl WM, Buyske J, Lietz A, Tempst P, Hunkarpillar M & De Lange RJ (1984) Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci USA 81:371.
von Versen R (1992) Experience in the processing of more than 50 000 bone grafts. In New trends in bone grafting, University of Tampere, Tampere, Finland.
Viljanen VV (1997) Allogeneic and xenogeneic bone morphogenetic protein in skeletal recontruction. Thesis, Acta Universitatis Tamperensis 562.
Viljanen VV, Gao TJ, Marttinen A & Lindholm TS (1996) Partial purification and characterization of bone morphogenetic protein from bone matrix of the premature moose (Alces alces): Degradation of bone-inducing activity during storage. Eur Surg Res 28:447–60.
Virolainen P, Vuorio E & Aro HT (1993) Gene expression at graft-host interfaces of cortical bone allografts and autografts. Clin Orthop 297:144–9.
Vuola J, Taurio R, Göransson H & Asko-Seljävaara S (1998) Compressive strength of calcium carbonate and hydroxyapatite implants after bone-marrow-induced osteogenesis. Biomaterials 19:223–7.
Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, Sibley BS & Wozney JM (1988) Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 85:9484–88.
Wang EA, Rosen V, D’Alessandro JS, Bayduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, Luxenburg DP, McQuaid D, Moutsatsos IK, Nove J & Wozney JM (1990) recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87:2220–24.
Welch RD, Jones AL, Bucholz RW, Reinert CM, Tjia JS, Pierce WA, Wozney JM & Li XJ (1998) Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res 13(9):1483–90.
Wheeler DL, Chamberland DL, Schmitt JM, Buck DC, Brekke JH, Hollinger JO, Joh SP & Suh KW (1998) Radiomorphometry and biomechanical assessment of recombinant human bone morphogenetic protein 2 and polymer in rabbit radius osteotomy model. J Biomed Mater Res 43(4):365–73.
Wikesjo UM, Guglielmoni P, Promsudthi A, Cho KS, Trombelli L, Selvig KA, Jin L & Wozney JM (1999) Periodontal repair in dogs:effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 26(6):392–400.
Wilkins RM, Kelly CM & Giusti DE (1999) Bioassayed demineralized bone matrix and calcium sulfate: use in bone-grafting procedures. Ann Chir Gynaecol 88:180–5.
Winn SR, Uludag H & Hollinger JO (1999) Carrier systems for bone morphogenetic proteins. Clin Orthop 367S:S95–S106.
Wolfe MW & Cook SD (1994) Use of osteoinductive implants in the treatment of bone defects. Med Prog Tech 20:155–68.
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM & Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242(4885):1528–34.
Wozney JM, Rosen V, Byrne M, Celeste AJ, Moutsatsos I & Wang EA (1990) Growth factors influencing bone development. J Cell Sci Suppl 13:149–56.
Wozney JM (1992) The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32(2):160–7.
Wozney JM & Rosen V (1998) Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 346:26–37.
Wu ZY & Hu XB (1988) Separation and purification of porcine bone morphogenetic protein. Clin Orthop 230:229–36.
Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM & Wang EA (1992) The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg 74–A (5):659–70.
Yoshida K, Bessho K, Fujimura K, Konishi Y, Kusumoto K, Ogawa Y & Iizuka T (1999) Enhancement by recombinant human bone morphogenetic protein-2 of bone formation by means of porous hydroxyapatite in mandibular bone defects. J Dent Res 78(9):1505–10.
Young C, Sandstedt P & Skoglund A (1999) A comparative study of anorganic xenogeneic bone and autogenous bone implants for bone regeneration in rabbits. Int J Oral Maxillofac Implants 14(1):72–6.
Yudell RM & Block MS (2000) Bone gap healing in the dog using recombinant human bone morphogenetic protein-2. J Oral Maxillofac Surg 58(7):761–6.
Zegzula HD, Buck DC, Brekke J, Wozney JM & Hollinger JO (1997) Bone formation with use of rhBMP-2 (Recombinant human bone morphognentic protein-2). J Bone Joint Surg 79–A (12):1778–90.
Zellin G & Linde A (1997) Treatment of segmental defects in long bones using osteopromotive membranes and recombinant human bone morphogenetic protein-2. An experimental study in rabbits. Scand J Plast Reconstr Hand Surg 31(2):97–104.